Cargando…
肺腺癌吉非替尼获得性耐药相关microRNAs的筛选鉴定
BACKGROUND AND OBJECTIVE: Acquired gefitinib-resistance was closely related to inefficiency of EGFRTKI treatment in lung adenocarcinoma. However, it was not clear that how microRNAs influenced the acquired gefitinibresistance in lung adenocarcinoma. The aim of this study is to screen and identify th...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999882/ https://www.ncbi.nlm.nih.gov/pubmed/21645449 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.18 |